Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Sen. Joseph Vitale

Gov. Christie, Lawmakers Move on Aggressive Bill to Tackle NJ Addiction Crisis

Drug Abuse help 2Trenton, NJ, January 25, 2017 — Susan K. Livio reports in The Star-Ledger that far-reaching legislation Gov. Chris Christie outlined in his State of the State address that would prevent opioid addiction and reduce economic barriers to inpatient drug treatment is expected to get a hearing as early as next week, one of the prime sponsors of the bill confirmed Monday.

Gov. Christie, in his Jan. 11 speech, said he wanted the Democrat-controlled legislature to pass the insurance bill within 30 days, while ordering Attorney General Christopher Porrino to quickly adopt rules limits opioid prescriptions.

Though still in the draft stage, the aggressive bill requires insurance companies to admit addicts without delay into an inpatient treatment program regardless of their ability to pay, for a maximum of six months, according to Senate Health Committee Chairman Joseph Vitale (D-Middlesex), one of bill’s prime sponsors. Continue reading